STOCK TITAN

Planet 13 Announces Closing of C$23 Million Bought Deal Public Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Planet 13 Holdings has completed its bought deal financing, raising C$23,019,550 through the sale of 6,221,500 units, priced at C$3.70 each. The financing attracted an additional 811,500 units due to the full exercise of the over-allotment option. Each unit comprises one common share and half a warrant, with a two-year exercise price of C$5.00. The net proceeds will support retail expansion outside Nevada and general corporate purposes. The Warrants will trade on the CSE under the symbol PLTH.WT.B.

Positive
  • Raised C$23,019,550 for growth and working capital.
  • Increased market reach with plans for retail expansion outside Nevada.
Negative
  • Potential dilution of shares due to the issuance of new Units.
  • Market reaction uncertainty given the volatile cannabis sector.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

LAS VEGAS, NV / ACCESSWIRE / September 10, 2020 / Planet 13 Holdings Inc. ("Planet 13" or the "Company") (CSE:PLTH)(OTCQX:PLNHF), a leading vertically-integrated Nevada cannabis company, is pleased to announce that it has completed its previously announced bought deal financing for aggregate gross proceeds of C$23,019,550 (the "Offering"). A total of 6,221,500 units (the "Units") of the Company were sold pursuant to the Offering, including an aggregate of 811,500 Units issued as a result of the full exercise of the Underwriters' (as defined herein) over-allotment option (the "Over-Allotment Option"), at a price of C$3.70 per Unit. The Offering was conducted by a syndicate of underwriters co-led by Beacon Securities Limited and Canaccord Genuity Corp. (collectively, the "Underwriters").

Each Unit consists of one common share (a "Common Share") in the capital of the Company and one- half of one Common Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant shall entitle the holder thereof to acquire one Common Share at an exercise price of C$5.00 per Common Share for a period of 24 months following the closing of the Offering.

"The outstanding performance of our Nevada operations in July and August and our resilience in the face of COVID-19 have allowed us to continue to focus on the execution of our long-term growth strategy", said Bob Groesbeck Co-CEO of Planet 13. "Our balance sheet is rock solid and we are actively looking for ways to bring Planet 13 to highly attractive markets."

The Company has received approval from the Canadian Securities Exchange ("CSE") to list the Warrants for trading on the CSE. The Warrants are expected to commence trading under the ticker symbol "PLTH.WT.B" on the date hereof.

The Underwriters received a cash commission equal to 6.0% of the gross proceeds from the sale of the Units pursuant to the Offering (including the gross proceeds raised pursuant to the full exercise of the Over-Allotment Option). The Underwriters also received compensation options (each a "Compensation Option") equal to 6.0% of the number of Units sold pursuant to the Offering (including the additional Units sold pursuant to the full exercise of the Over-Allotment Option). Each Compensation Option entitles the Underwriters to purchase one Common Share at a price of C$3.70 for a period of 24 months following the closing date of the Offering.

The net proceeds from the Offering will be used by the Company for retail expansion outside of Nevada and for working capital and general corporate purposes.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Planet 13
Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's Common Shares trade on the CSE under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, statements relating to information concerning the contemplated use of proceeds of the Offering.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; risks associated with COVID-19 and other infectious diseases presenting as major health issues; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MM Development Company, Inc. ("MMDC"). Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business, including COVID-19, are disclosed in the Company's public filings including its (final) short form prospectus dated September 2, 2020 (including the documents incorporated by reference therein) filed on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

For further inquiries, please contact:
Robert Groesbeck or Larry Scheffler
Co-Chief Executive Officers
ir@planet13lasvegas.com

Mark Kuindersma, CFA
LodeRock Advisors Inc., Planet 13 Investor Relations
mark.kuindersma@loderockadvisors.com
416-519-2156 ext. 2230

SOURCE: Planet 13 Holdings



View source version on accesswire.com:
https://www.accesswire.com/605518/Planet-13-Announces-Closing-of-C23-Million-Bought-Deal-Public-Offering

FAQ

What are the details of Planet 13's financing deal announced in September 2020?

Planet 13 completed a bought deal financing of C$23,019,550, selling 6,221,500 units at C$3.70 each.

What will the proceeds from the C$23 million financing be used for?

The proceeds will be used for retail expansion outside Nevada and working capital.

What is the significance of the warrants issued by Planet 13?

Each warrant allows the purchase of one common share at C$5.00 for 24 months, potentially increasing shareholder value.

How does the financing impact Planet 13's stock symbol PLNHF?

The financing could affect liquidity and investor sentiment towards PLNHF, particularly concerning dilution.

Planet 13 Holdings Inc.

OTC:PLNHF

PLNHF Rankings

PLNHF Latest News

PLNHF Stock Data

195.57M
135.45M
39.65%
0.34%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Las Vegas